Eurand, Inc. v. Anchen Pharmaceuticals, Inc.

Federal Circuit

Eurand, Inc. v. Anchen Pharmaceuticals, Inc.

427 F. App'x 901

CourtCourt of Appeals for the Federal Circuit

DecidedAugust 31, 2011

DocketNos. 2011-1408, 2011-1410, 2011-1411, 2011-1412

StatusPublished

This text of 427 F. App'x 901 (Eurand, Inc. v. Anchen Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Eurand, Inc. v. Anchen Pharmaceuticals, Inc., 427 F. App'x 901 (Fed. Cir. 2011).

Pincite

Opinion

ON MOTION

ORDER

Upon consideration of the appellants’ motion to withdraw these appeals, and the motion to revise the official caption,

It Is Ordered That:

(1) The motion to withdraw the appeals is granted. The appeals are dismissed.

(2) The motion to revise the caption is granted. The revised official caption is reflected above.

(3) Each side shall bear its own costs.

(4) Any other pending motions are denied as moot.

Free access — add to your briefcase to read the full text and ask questions with AI